Infectious Diseases (except HIV/AIDS)
Showing page 273 of 716 pages of list content
-
Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study
This article's authors -
Multi-ethnic Investigation of Risk and Immune Determinants of COVID-19 Outcomes
This article's authors -
Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 Variants
This article's authors -
Vaccine-induced humoral and cellular immunity against SARS-CoV-2 at 6 months post BNT162b2 vaccination
This article's authors -
Multiplex PCR Assays for Identifying All Major SARS-CoV-2 Variants
This article's authors -
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine
This article's authors -
Implementation and extended evaluation of the Euroimmun Anti-SARS-CoV-2 IgG assay and its contribution to the United Kingdom’s COVID-19 public health response
This article's authors -
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
This article's authors -
How many lives do COVID vaccines save? Evidence from Israel
This article's authors -
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults ≥ 65 years of age: a Phase II, open-label study
This article's authors